Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Colucci

Showing results (91-100 of 135) with videos related to

Pageof 14
Sort By:
Oncology Reports|November 8, 2005
Topotecan plus ifosfamide in patients with platinum refractory advanced/metastatic non-small cell lung cancer: a phase II trialVito Lorusso, Vittorio Gebbia, Massimiliano Spada, et al.
Tumori|November 10, 2005
Cost of insurance policies for investigator-initiated cancer clinical trials in ItalyFrancesco Perrone, Maurizio Marangolo, Francesco Di Costanzo, et al.
The Oncologist|January 7, 2010
Early skin toxicity as a predictive factor for tumor control in hepatocellular carcinoma patients treated with sorafenibBruno Vincenzi, Daniele Santini, Antonio Russo, et al.
Expert Opinion on Therapeutic Targets|March 27, 2012
Optimized granulocyte colony-stimulating factor prophylaxis in adult cancer patients: from biological principles to clinical guidelinesNicola Silvestris, Marzia Del Re, Amalia Azzariti, et al.
Lung Cancer (Amsterdam, Netherlands)|November 14, 2009
First-line cisplatin with docetaxel or vinorelbine in patients with advanced non-small-cell lung cancer: a quality of life directed phase II randomized trial of Gruppo Oncologico Italia MeridionaleVittorio Gebbia, Vito Lorusso, Domenico Galetta, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 13, 2011
A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM studyPatrizia Vici, Giuseppe Colucci, Francesco Giotta, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 29, 2011
Different kinetics of HBV and HCV during haemodialysis and absence of seronegative viral hepatitis in patients with end-stage renal diseaseIngmar Mederacke, Matthias Meier, Johann B Lüth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2007
Epidermal growth factor receptor gene copy number and clinical outcome of metastatic colorectal cancer treated with panitumumabAndrea Sartore-Bianchi, Mauro Moroni, Silvio Veronese, et al.
Clinical Lung Cancer|August 12, 2011
Induction pemetrexed and cisplatin followed by maintenance pemetrexed versus carboplatin plus paclitaxel plus bevacizumab followed by maintenance bevacizumab: a quality of life-oriented randomized phase III study in patients with advanced non-squamous non-small-cell lung cancer (ERACLE)Domenico Galetta, Salvatore Pisconti, Saverio Cinieri, et al.
Oncology|April 9, 2011
Cetuximab plus FOLFOX-4 in untreated patients with advanced colorectal cancer: a Gruppo Oncologico dell'Italia Meridionale Multicenter phase II studyGiuseppe Colucci, Francesco Giuliani, Carlo Garufi, et al.
Pageof 14

Showing results (91-100 of 135) with videos related to

Sort By:
Pageof 14
Oncology Reports|November 8, 2005
Topotecan plus ifosfamide in patients with platinum refractory advanced/metastatic non-small cell lung cancer: a phase II trialVito Lorusso, Vittorio Gebbia, Massimiliano Spada, et al.
Tumori|November 10, 2005
Cost of insurance policies for investigator-initiated cancer clinical trials in ItalyFrancesco Perrone, Maurizio Marangolo, Francesco Di Costanzo, et al.
The Oncologist|January 7, 2010
Early skin toxicity as a predictive factor for tumor control in hepatocellular carcinoma patients treated with sorafenibBruno Vincenzi, Daniele Santini, Antonio Russo, et al.
Expert Opinion on Therapeutic Targets|March 27, 2012
Optimized granulocyte colony-stimulating factor prophylaxis in adult cancer patients: from biological principles to clinical guidelinesNicola Silvestris, Marzia Del Re, Amalia Azzariti, et al.
Lung Cancer (Amsterdam, Netherlands)|November 14, 2009
First-line cisplatin with docetaxel or vinorelbine in patients with advanced non-small-cell lung cancer: a quality of life directed phase II randomized trial of Gruppo Oncologico Italia MeridionaleVittorio Gebbia, Vito Lorusso, Domenico Galetta, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 13, 2011
A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM studyPatrizia Vici, Giuseppe Colucci, Francesco Giotta, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 29, 2011
Different kinetics of HBV and HCV during haemodialysis and absence of seronegative viral hepatitis in patients with end-stage renal diseaseIngmar Mederacke, Matthias Meier, Johann B Lüth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2007
Epidermal growth factor receptor gene copy number and clinical outcome of metastatic colorectal cancer treated with panitumumabAndrea Sartore-Bianchi, Mauro Moroni, Silvio Veronese, et al.
Clinical Lung Cancer|August 12, 2011
Induction pemetrexed and cisplatin followed by maintenance pemetrexed versus carboplatin plus paclitaxel plus bevacizumab followed by maintenance bevacizumab: a quality of life-oriented randomized phase III study in patients with advanced non-squamous non-small-cell lung cancer (ERACLE)Domenico Galetta, Salvatore Pisconti, Saverio Cinieri, et al.
Oncology|April 9, 2011
Cetuximab plus FOLFOX-4 in untreated patients with advanced colorectal cancer: a Gruppo Oncologico dell'Italia Meridionale Multicenter phase II studyGiuseppe Colucci, Francesco Giuliani, Carlo Garufi, et al.
Pageof 14